144 filings
Page 4 of 8
PRE 14A
zw6gvdvw1c lmw
14 Apr 22
Preliminary proxy
4:10pm
S-8
ldooc96hgd1o20zrybt4
23 Feb 22
Registration of securities for employees
4:20pm
8-K
m3p9498jck5pt xiax
23 Feb 22
Allogene Therapeutics Reports Fourth Quarter and Full Year 2021
4:08pm
8-K
tdw3b9
15 Dec 21
Entry into a Material Definitive Agreement
10:09am
8-K
knb5kyitdbae 66l
4 Nov 21
Allogene Therapeutics Reports Third Quarter 2021 Financial Results and Business Update
4:13pm
CT ORDER
gzkie0
25 Oct 21
Confidential treatment order
8:44am
8-K
kmqkfdiyo
7 Oct 21
Other Events
4:20pm
8-K
tyav6hk 6u46
4 Aug 21
Allogene Therapeutics Reports Second Quarter 2021 Financial Results
4:37pm
8-K
19am0npd4og
2 Aug 21
Departure of Directors or Certain Officers
4:29pm
8-K
i9k skc82s
15 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
wuw qtkdmmc7sgkd
20 May 21
Departure of Directors or Certain Officers
5:20pm
8-K
rn5fyj n0c
19 May 21
Other Events
5:04pm
8-K
wd5e3er
5 May 21
Allogene Therapeutics Reports First Quarter 2021 Financial Results
4:20pm
DEFA14A
o50ceq
22 Apr 21
Additional proxy soliciting materials
4:29pm
S-8
57t8k6p8p6uj9xqdahi
25 Feb 21
Registration of securities for employees
5:02pm